Pharmaceutical composition for cancer treatment, process for its preparation, and its use

A pharmaceutical composition for cancer treatment of mammalian and/or other vertebrate comprising:

• a pharmaceutically acceptable carrier;
• and
• one or more polypeptides comprising one or more sequences having 70% or greater similarity to SEQ ID No:
• 6, or one or more sequences having 70% identity or greater with SEQ ID No:
• 6;
• or
• one or more gene constructs useful for the expression in mammals and/or other vertebrates of one or more polypeptides as defined above.

A method for the cancer treatment of mammals and/or other vertebrates comprising the use of a pharmaceutical composition comprising:

• one or more polypeptides comprising one or more sequences having equal or greater than 70% of similarity to SEQ ID No:
• 6, or one or more sequences having an equal or greater than 70% of identity with SEQ ID No:
• 6;
• or
• one or more gene constructs useful for the expression of one or more of said polypeptides,
• wherein the mammals and/or other vertebrates are treated with a pharmaceutically effective amount of the pharmaceutical composition.

A process for the preparation of a pharmaceutical composition for cancer treatment of mammalian and/or other vertebrate cancer comprising a mixing step for mixing:

• one or more polypeptides comprising one or more sequences having equal or greater than 70% similarity to SEQ ID No:
• 6, or one or more sequences having an identity equal or greater than 70% identity with SEQ ID No:
• 6;
• or
• one or more gene constructs useful for the expression in mammals and/or other vertebrates of one or more of said polypeptides;
• and
• a pharmaceutically acceptable carrier.